UGC
Market HighlightsThe global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period.Preclinical imaging solutions are used during the preclinical research for visualization of living animals.preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging.Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7365 Technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to drive the growth of preclinical imaging market.The Alzheimer’s Drug Discovery Foundation was providing the funding opportunity for preclinical study up to USD 5 million.Similarly, in 2015 Deutsches Zentrum für Herz-Kreislaufforschung e.V.This funding supports the market growth.Regional AnalysisGeographically, the Americas is expected to dominate the global preclinical imaging market owing to the presence of well-established players, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches.
UGC
Preclinical Imaging Market Analysis  The global preclinical imaging market was valued USD 2.01 billion in 2017 and is likely to develop at a 6.3% CAGR between 2018- 2023, according to the recent Market Research Future (MRFR) report.Preclinical imaging, simply put, is a means of visualizing living animals for research purposes like drug development.It has wide applications, including cardiac imaging, orthopedic, functional & anatomical neuroimaging, cancer research, infectious diseases, inflammation, cardiology, and neurology.Various factors are adding to the global preclinical imaging market growth.Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7365On the contrary, procedural and technological limitations related to standalone systems, significant operational and installation costs related to preclinical imaging modalities, and strict regulatory framework which governs preclinical researchers are factors that may limit the global preclinical imaging market growth over the forecast period.By modality, the global preclinical imaging market is segmented into magnetic particle imaging systems, photoacoustic imaging system, micro-CT, micro-ultrasound, micro-MRI, nuclear imaging systems, and optical imaging systems.
UGC
Market HighlightsThe global preclinical imaging market size anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period.Preclinical imaging solutions are used during the preclinical research for visualization of living animals.preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging.Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7365   Technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to drive the growth of preclinical imaging market.The Alzheimer's Drug Discovery Foundation was providing the funding opportunity for preclinical study up to USD 5 million.Similarly, in 2015 Deutsches Zentrum für Herz-Kreislaufforschung e.V.This funding supports the market growth.Regional AnalysisGeographically, the Americas is expected to dominate the global preclinical imaging market owing to the presence of well-established players, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches.
UGC
Market HighlightsThe global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period.Preclinical imaging solutions are used during the preclinical research for visualization of living animals.preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging.Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7365 Technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches are expected to drive the growth of preclinical imaging market.The Alzheimer's Drug Discovery Foundation was providing the funding opportunity for preclinical study up to USD 5 million.Similarly, in 2015 Deutsches Zentrum für Herz-Kreislaufforschung e.V.This funding supports the market growth.Regional AnalysisGeographically, the Americas is expected to dominate the global preclinical imaging market owing to the presence of well-established players, technological advancements in the field of molecular imaging, increasing market demand for non-invasive small-animal imaging techniques, and increasing funding to support preclinical researches.
1
UGC
 Pseudotumor Cerebri Market Research Report: By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023Market HighlightsIt is estimated that the Pseudotumor Cerebri Market is expected to grow at a CAGR 6.0% during the forecast period of 2017-2023.Headache is the most common symptom of this condition, a persistent symptom in around 93% of patients, with pseudotumor cerebri, at the time of diagnosis.A number of factors such as increasing technological advancements, and growing prevalence of obesity, are propelling the growth of the global pseudotumor cerebri market.An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market.However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period.Regional AnalysisThe Americas dominate the pseudotumor cerebri market owing to the rising occurrence of pseudotumor cerebri in this region, and technological advancements.According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age.It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivityEurope holds the second position in the pseudotumor cerebri market.It is found that the government support towards research & development, and favourable amendments in the reimbursement policies in the healthcare is likely to drive the European pseudotumor cerebri market.Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology.
UGC
The Business Research Company published its Brain And Neuroimaging Devices Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Brain And Neuroimaging Devices market.The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the Brain And Neuroimaging Devices market’s segments- 1) By Imaging Type: Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG), Others2) By End-user: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers.View Complete Report:https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report-2020-30-covid-19-growth-and-changeBrain And Neuroimaging Devices Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.The chapter also covers markets which have been positively affected by the pandemic.The global brain and neuroimaging devices market is expected to decline from $32.83 billion in 2019 to $31.43 billion in 2020 at a compound annual growth rate (CAGR) of -4.28%.The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
(Rensselaer Polytechnic Institute) In a new article in IEEE Transactions on Biomedical Engineering, researchers demonstrated how a deep learning framework they call "Brain-NET" can accurately predict a person's level of expertise in terms of their surgical motor skills, based solely on neuroimaging data.
UGC
Pseudotumor Cerebri Market Research Report: By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023Market HighlightsIt is estimated that the Pseudotumor Cerebri Market Trends is expected to grow at a CAGR 6.0% during the forecast period of 2017-2023.Headache is the most common symptom of this condition, a persistent symptom in around 93% of patients, with pseudotumor cerebri, at the time of diagnosis.A number of factors such as increasing technological advancements, and growing prevalence of obesity, are propelling the growth of the global pseudotumor cerebri market.An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market.However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period.According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age.It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivityEurope holds the second position in the pseudotumor cerebri market.It is found that the government support towards research & development, and favourable amendments in the reimbursement policies in the healthcare is likely to drive the European pseudotumor cerebri market.Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology.
UGC
Pseudotumor Cerebri Market Research Report: By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023  Market Highlights It is estimated that the Pseudotumor Cerebri Market is expected to grow at a CAGR 6.0% during the forecast period of 2017-2023.Headache is the most common symptom of this condition, a persistent symptom in around 93% of patients, with pseudotumor cerebri, at the time of diagnosis.A number of factors such as increasing technological advancements, and growing prevalence of obesity, are propelling the growth of the global pseudotumor cerebri market.An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market.However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period.According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age.It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivityEurope holds the second position in the pseudotumor cerebri market.As per the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014-2015.The Middle East & Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.
UGC
Pseudotumor Cerebri Market Research Report: By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023 Market HighlightsIt is estimated that the Pseudotumor Cerebri Industry is expected to grow at a CAGR 6.0% during the forecast period of 2017-2023.An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market.However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period.According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age.It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivityEurope holds the second position in the pseudotumor cerebri market.It is found that the government support towards research & development, and favourable amendments in the reimbursement policies in the healthcare is likely to drive the European pseudotumor cerebri market.Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology.As per the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014-2015.The Middle East & Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.
UGC
Pseudotumor Cerebri Market Research Report: By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023 Market HighlightsIt is estimated that the Pseudotumor Cerebri Market is expected to grow at a CAGR 6.0% during the forecast period of 2017-2023.An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market.However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period.According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age.It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivityEurope holds the second position in the pseudotumor cerebri market.It is found that the government support towards research & development, and favourable amendments in the reimbursement policies in the healthcare is likely to drive the European pseudotumor cerebri market.Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology.As per the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014-2015.The Middle East & Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.
UGC
Pseudotumor Cerebri Market Research Report: By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023Market HighlightsIt is estimated that the Pseudotumor Cerebri Industry is expected to grow at a CAGR 6.0% during the forecast period of 2017-2023.An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market.However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period.Regional AnalysisThe Americas dominate the pseudotumor cerebri market owing to the rising occurrence of pseudotumor cerebri in this region, and technological advancements.According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age.It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivityEurope holds the second position in the pseudotumor cerebri market.It is found that the government support towards research & development, and favourable amendments in the reimbursement policies in the healthcare is likely to drive the European pseudotumor cerebri market.Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology.As per the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014-2015.The Middle East & Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.Access Report Details @ https://www.marketresearchfuture.com/reports/pseudotumor-cerebri-market-5709SegmentationThe global pseudotumor cerebri market is segmented on the basis of diagnosis, treatment, and end user.By the diagnosis, the market is classified as fundoscopy, neuroimaging, lumbar puncture, and others.On the basis of the treatment, the market is classified as surgery, medication, and others.
UGC
Pseudotumor Cerebri Treatment Market Research Report: By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023Market Highlights It is estimated that the Pseudotumor Cerebri Treatment Market is expected to grow at a CAGR 6.0% during the forecast period of 2017-2023.Pseudotumor Cerebri, also known as idiopathic intracranial hypertension, is a challenging condition with a rapidly increasing prevalence due to a close relation to obesity.An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market.However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period.According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age.It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivityEurope holds the second position in the Pseudotumor Cerebri Treatment Market.It is found that the government support towards research & development, and favourable amendments in the reimbursement policies in the healthcare is likely to drive the European Pseudotumor Cerebri Treatment Market.Asia Pacific is the fastest growing Pseudotumor Cerebri Treatment Market owing to a huge patient pool and development in healthcare technology.
UGC
Pseudotumor Cerebri Market Research Report: By Diagnosis (Fundoscopy, Neuroimaging, And Lumbar Puncture), By Treatment (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication), By The End User – Global Forecast Till 2023Market Highlights It is estimated that the Pseudotumor Cerebri Market is expected to grow at a CAGR 6.0% during the forecast period of 2017-2023.Pseudotumor Cerebri, also known as idiopathic intracranial hypertension, is a challenging condition with a rapidly increasing prevalence due to a close relation to obesity.An increased incidence of pseudotumor cerebri, unmet medical needs, improving regulatory framework, increasing government assistance, increasing adoption rate of new technology, and improvement in funding and improved reimbursement policies are also boosting the growth of the market.However, cost of treatment, side-effects associated with surgical interventions, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the forecast period.According to the study suggested by International Ophthalmology Clinics in 2014, the annual incidence of idiopathic intracranial hypertension in the Western world is around 0.9 per 100,000 individuals and 3.5 per 100,000 in females, in between 15 to 44 years of age.It is also reported that the annual cost of idiopathic intracranial hypertension in the United States had been exceeded to USD 444 million due to frequent hospitalizations, and its inclination in young working-age adults which results in a significant loss of productivityEurope holds the second position in the pseudotumor cerebri market.It is found that the government support towards research & development, and favourable amendments in the reimbursement policies in the healthcare is likely to drive the European pseudotumor cerebri market.Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology.
More

Top